Shares of GH Research rose on plans to provide an update on the status of its investigational new drug application for GH001, a therapy for treatment-resistant depression. The stock climbed 19% to $15 ...
GH Research plans to provide an update on the status of its investigational new drug application for GH001, a therapy for treatment-resistant depression.
The death of a young biathlete has refocused attention on hypoxic training masks, especially their cardiovascular effects, in ...
News-Medical.Net on MSN
New mouse model enables study of chronic lung infections in aging
Respiratory infections are among the leading causes of illness and death in the elderly, driven by immune aging, chronic ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of KANDLELIT-007, a ...
Two patients present with rash eruptions on different parts of the body. Can you correctly identify each case?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback